Bank of America’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $134 | Hold |
|
|||||
|
2023
Q1 | $240 | Buy |
|
|||||
|
2022
Q4 | $114 | Sell |
|
|||||
|
2022
Q3 | $1K | Sell |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $12K | Sell |
|
|||||
|
2021
Q4 | $20K | Sell |
|
|||||
|
2021
Q3 | $46K | Sell |
|
|||||
|
2021
Q2 | $47K | Sell |
|
|||||
|
2021
Q1 | $194K | Buy |
|
|||||
|
2020
Q4 | $92K | Buy |
|
|||||
|
2020
Q3 | $66K | Sell |
|
|||||
|
2020
Q2 | $275K | Buy |
|
|||||
|
2020
Q1 | $156K | Sell |
|
|||||
|
2019
Q4 | $239K | Sell |
|
|||||
|
2019
Q3 | $235K | Sell |
|
|||||
|
2019
Q2 | $308K | Buy |
|
|||||
|
2019
Q1 | $263K | Sell |
|
|||||
|
2018
Q4 | $195K | Buy |
|
|||||
|
2018
Q3 | $158K | Buy |
|
|||||
|
2018
Q2 | $197K | Buy |
|
|||||
|
2018
Q1 | $33K | Sell |
|
|||||
|
2017
Q4 | $32K | Buy |
|
|||||
|
2017
Q3 | $26K | Sell |
|
|||||
|
2017
Q2 | $40K | Hold |
|
|||||
|
2017
Q1 | $33K | Buy |
|
|||||
|
2016
Q4 | $14K | Hold |
|
|||||
|
2016
Q3 | $17K | Sell |
|
|||||
|
2016
Q2 | $35K | Sell |
|
|||||
|
2016
Q1 | $34K | Sell |
|
|||||
|
2015
Q4 | $79K | Buy |
|
|||||
|
2015
Q3 | $48K | Buy |
|
|||||
|
2015
Q2 | $15K | Buy |
|
|||||
|
2015
Q1 | $9K | Hold |
|
|||||
|
2014
Q4 | $4K | Sell |
|
|||||
|
2014
Q3 | $58K | Buy |
|
|||||
|
2014
Q2 | $51K | Hold |
|
|||||
|
2014
Q1 | $56K | Sell |
|
|||||
|
2013
Q4 | $78K | Buy |
|
|||||
|
2013
Q3 | $68K | Hold |
|
|||||
|
2013
Q2 | $52K | Buy |
|